Bristol Myers Squibb (NYSE:BMY) and Bain Capital have announced the establishment of a new independent biopharmaceutical ...

Anne Hoecker, Bain & Company's head of global technology practice, joins CNBC's 'Squawk on the Street' to discuss the growth ...

Bain Capital’s exit leaves Perpetual negotiating with Oaktree-backed financial planner roll-up AZ Next Generation Advisory.

Bain Capital's Bridge Data Centres (Bridge DC) has broken ground on a facility in Thailand. Located south of Bangkok in the ...

Large private investment firm, Bain Capital, plans to sell its majority stake in an insurance broker and agency network based ...

The most successful carve-out acquisitions start with due diligence that identifies both the carve-out-specific elements and ...

During the K-pop boy band's JUST ODD World Tour, JUSTB reflect on supporting Bain coming out as K-pop's first active star despite industry stigma.

Since Bain took over partial ownership in 2005, after Romney left the company, Toys "R" Us has maintained roughly the same number of stores, with about 1,600 retail locations worldwide.

Articles about Bain Capital, the private equity behemoth known for turning businesses around—or tearing them apart, depending on your perspective.

The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which ...

Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...

Bain Capital and Bristol Myers Squibb have formed a new biopharmaceutical company focused on developing new therapies for autoimmune diseases. The newly formed company launches with a $300 million ...